Vulvar Lymphangiosarcoma in a Bitch

Authors

  • Isabella de Almeida Fabris Departamento de Cirurgia e Anestesiologia Veterinária, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, SP, Brazil.
  • Marconi Rodrigues de Farias Clínica Veterinária Escola (CVE), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, PR, Brazil.
  • Juliana Werner Laboratório Werner & Werner, Curitiba, Paraná, Brazil.
  • Vinicius Gonzales Peres Albernaz Departamento de Cirurgia e Anestesiologia Veterinária, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, SP, Brazil.
  • Taíse Fuchs Departamento de Medicina Veterinária, Universidade Positivo, Curitiba.
  • Liv Cristina Miara Clínica Veterinária Escola (CVE), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, PR, Brazil.
  • Juliany Gomes Quitzan Departamento de Cirurgia e Anestesiologia Veterinária, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, SP, Brazil.

DOI:

https://doi.org/10.22456/1679-9216.86087

Abstract

Background: Lymphangiosarcoma (LSA) is a rare, highly malignant and infiltrative neoplasm of the lymphatic endothelium of dogs and cats. It is mostly reported in medium to large breed dogs, over 5-year-old, with no sexual predisposition. Affected animals present fluctuating and diffuse swelling, covering both dermis and subcutaneous tissue, spreading through lymphatic and haematic vessels. Histologically, LSA is characterized by connected channels devoid of conspicuous haematic elements. Treatment depends on location of the neoplasm, staging, and possibility of curative surgical excision. Chemotherapy and radiotherapy can increase survival time. In this report, we describe a rare case of vulvar LSA in a dog. This is the first Brazilian report of LSA in dogs so far.

Case: A 3-year-old, female, mixed breed dog was presented for evaluation of vesicle-bullous lesions in the vulvar and perivulvar region with progressive growth along 6 month. Histopathology revealed neoplastic proliferation in the superficial dermis, advancing through the profound dermis. The histological lesion pattern was consistent with angiosarcoma, which united along with macroscopic pattern of the tumor, and the presence of multiple anastomosed vascular structures without erythrocytes within it at microscopy, was compatible with LSA. No evidence of metastasis or lymphadenopathy was found on survey radiography and ultrasound. We performed a surgical excision, and remaining wound was reconstructed with an advancement skin flap. Despite wide surgical resection, neoplastic cells could be found in surgical borders, as well as a metastatic inguinal lymph node. Postoperative chemotherapy based on doxorubicin as a single agent was administrated. Disease free interval (DFI) was one month after surgery, when small bullous lesions were observed near the surgical site, and histopathological exam confirmed LSA. Three months after the surgical procedure, the patient presented with worsening of the lesions, anorexia, and apathy. The owner opted for euthanasia. Total survival time was five months.

Discussion: The LSA occurs often in dogs above five years old, unlike this case, in which the patient was 3 years old. Several anatomic locations were cited in other reports. In this case, the lesion was in both the vulvar and perivulvar regions, which is an uncommon location of LSA, described as secondarily affected region in one report only. Despite absence of metastasis in this case, lungs, kidneys, bone marrow, and spleen can be affected. Histopathologic exam is the golden standard for a definitive diagnose of LSA. Diagnosing LSA may be challenging due to its resemblance to hemangiosarcoma, and confirmation is only possible if histopathology detects an absence of red blood cells in the lymphatic channels. Prognosis is poor due to LSA aggressive and infiltrative features. Doxorubicin demonstrated good clinical response in other dogs. Chemotherapy protocols, whether alone or in combination with cyclophosphamide, have been proving to be promising in dogs with soft tissue sarcomas, such as LSA. Surgical approach is the most appropriate and it may be associated with radiotherapy or chemotherapy, especially if complete resection of the tumor is not possible. In this report, even though it was a young animal, the location and extension of the lesion did not contribute to the good prognosis, even after adding adjuvant chemotherapy to the treatment.

Downloads

Download data is not yet available.

References

Barnes J.C., Taylor S.M., Clark E.G., Haines D.M. & Broughton S.J. 1997. Disseminated lymphangiosarcoma in a dog. Canadian Veterinary Journal. 38(1): 42-44.

Chung K.C., Kim H.J.E. & Jeffers L.L.C. 2000. Lymphangiosarcoma (Stewart-Treves syndrome) in postmastectomy patients. Journal of Hand Surgery (American Volume). 25(6): 1163-1168.

Curran K.M., Halsey C.H.C. & Worley D.R. 2014. Lymphangiosarcoma in 12 dogs: a case series (1998-2013).Veterinary and Comparative Oncology. 14(2): 181-190.

Diessler M.E., Castellano M.C., Massone A.R., Portiansky E.L., Allende M.G., Idiart J.R. & Gimeno EJ. 2003. Cutaneous lymphangiosarcoma in a young dog: Clinical, anatomopathological and lectinhistochemical description. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine. 50(9): 452-456.

Fossum T.W., Miller M.W. & Mackie J.T. 1998. Lymphangiosarcoma in a dog presenting with massive head and neck swelling. Journal of American Animal Hospital Association. 34(4): 301-304.

Franklin R.T., Robertson J.R. & Thornburg L.P. 1984. Lymphangiosarcoma in a dog. Journal of the American Veterinary Medical Association. 184(4): 474-475.

Gross T.L., Ihrke P.J., Walder E.J. & Affolter V.K. 2005. Interface Diseases of the dermal-epidermal junction. In: Gross T.L., Ihrke P.J., Walder E.J. & Affolter V.K. (Eds). Skin diseases of the dog and cat: clinical and histopathologic diagnosis. 2nd edn. Oxford: Blackwell Publishing, pp.753-757.

Itoh T., Mikawa K., Mikawa M., Nibe K. & Uchida K. 2004. Lymphangiosarcoma in a dog treated with surgery and

chemotherapy. Journal of Veterinary Medical Science. 66(2): 197-199.

Kelly W.R., Wilkinson G.T. & Allen P.W. 1981. Canine angiosarcoma (lymphangiosarcoma).Veterinary Pathology.

(2): 224-227.

Lamb W.A. & Muir P. 1994. Lymphangiosarcoma associated with hyponatraemia and hyperkalaemia in a dog. Journal of Small Animal Practice. 35(7): 374-376.

Looper J.S. 2007. Fat necrosis simulating recurrent neoplasia following external beam radiotherapy in a dog. Veterinary

Radiology & Ultrasound. 48(1): 86-88.

Marcinowska A., Warland J., Brearley M. & Dobson J. 2013. A novel approach to treatment of lymphangiosarcoma in a boxer dog. Journal of Small Animal Practice. 54(6): 334-337.

Messonnier S. 1990. Letter to the editor: lymphangiosarcoma. Journal of American Animal Hospital Association. 26(3): 242.

Mineshige T., Sugahara G., Ohmuro T., Kamiie J. & Shirota K. 2015. Lymphangiosarcoma with bone formation of the auricle in a dog. Journal of Veterinary Medical Science. 77(6): 739-742.

Myers N.C., Engler S.J. & Jakowski R.M. 1996. Chylothorax and chylous ascites in a dog with mediastinal lymphangiosarcoma.

Journal of American Animal Hospital Association. 32(3): 263-269.

Rudd R.G., Veatch J.K., Whitehair J.G., Withrow S.J. & Cook J.E. 1989. Lymphangiosarcoma in dogs. Journal of American Animal Hospital Association. 25: 695-698.

Ryan S., Wouters E.G.H., Nimwegen S. & Kirpenstejin J. 2012. Skin and subcutaneous tumors. In: Kudnig S.T. & Séguin B. (Eds). Veterinary Surgical Oncology. New York: John Wiley & Sons, pp.55-85.

Sagartz J.E., Lairmore D.H., Sheafor S.E. & Couto C.G. 1996. Lymphangiosarcoma in a Young Dog. Veterinary Pathology. 33(3): 353-356.

Shiga A., Shirota K., Une Y. & Nomura Y. 1994. Lymphangiosarcoma in a dog. Journal of Veterinary Medical Science. 56(6): 1199-1202.

Sicotte V., Benamou J., Fifle L.C., Planté J., Hugues I.L., Joly H. & Stern A.W. 2012. Use of surgery and mitoxantrone

chemotherapy in a dog with disseminate lymphangiosarcoma. Journal of the American Veterinary Medical Association. 241(12): 1639-1644.

Waldrop J.E., Pike F.S., Dulisch M.L., Ortega T.M. & Gliatto J.M. 2001. Chylothorax in a dog with pulmonar lymphangiosarcoma. Journal of American Animal Hospital Association. 37(1): 81-85.

Webb J.A., Boston S.W., Armstrong J. & Moens N.M.M. 2004. Lymphangiosarcoma Associated with Primary Lymphedema in a Bouvier des Flandres. Journal of Veterinary Internal Medicine. 18(1): 122-124.

Williams J.H. 2005. Lymphangiosarcoma of dogs: a review. Journal of the South African Veterinary Association. 76(3):

-131.

Williams J.H., Birrell J. & Van Wilpec E. 2005. Lymphangiosarcoma in a 3.5-year-old Bullmastiff bitch with vaginal prolapse, primary lymph node fibrosis and other congenital defects. Journal of the South African Veterinary Association.

(3): 165-171.

Withrow S.J., Vail D.M. & Page R.L. 2013. Small Animal Clinical Oncology. 5th edn. St. Louis: Elsevier Saunders, pp.370-383.

Published

2017-01-01

How to Cite

Fabris, I. de A., de Farias, M. R., Werner, J., Albernaz, V. G. P., Fuchs, T., Miara, L. C., & Quitzan, J. G. (2017). Vulvar Lymphangiosarcoma in a Bitch. Acta Scientiae Veterinariae, 45, 6. https://doi.org/10.22456/1679-9216.86087

Most read articles by the same author(s)